Regional Head and Face Pain Relief Following Lower Cervical Intramuscular Anesthetic Injection

Headache

Volumn 43, Issue 10, 2003, Pages 1109-1111

  Mellick, Gary A ^a   Mellick, Larry B ^b  

^a American Pain Specialists Inc   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cephalgia; Cervical injection; Facial pain; Headache; IHS classification; Migraine; Neurovascular headache; Postherpetic neuralgia; Trigeminal neuralgia; Trigeminovascular system

Indexed keywords

ANESTHETIC AGENT; BUPIVACAINE; GABAPENTIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PETHIDINE; RIZATRIPTAN;

ADULT; ALLODYNIA; ANESTHESIA MECHANISM; ARTICLE; CERVICAL SPINE; CHRONIC PAIN; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EVALUATION; FACE PAIN; FEMALE; HEADACHE; HUMAN; HYPERALGESIA; INTRACTABLE PAIN; MALE; MIGRAINE; NAUSEA; NECK MUSCLE; NECK PAIN; PATIENT SELECTION; PHONOPHOBIA; PHOTOPHOBIA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SCALP; SYMPTOMATOLOGY; TENSION HEADACHE; TISSUE DISTRIBUTION; TRIGEMINUS NEURALGIA; VOMITING;

ADULT; AGED; ANESTHETICS, LOCAL; BUPIVACAINE; CERVICAL VERTEBRAE; CHRONIC DISEASE; FACIAL NEURALGIA; FEMALE; HEADACHE DISORDERS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MIGRAINE DISORDERS; TENSION-TYPE HEADACHE; TRIGEMINAL NEURALGIA;

EID: 0346750810     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03214.x     Document Type: Article

References (13)

1. Messinger HB, Spierings EL, Vincent AJ. Overlap of migraine and tension-type headache in the International Headache Society classification. Cephalalgia. 1991;11:233-237.
2. Cady RK, Gutterman D, Saiers JA, et al. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia. 1997;7:588-590.
3. Blumenthal HJ, Rappoport AM. The clinical spectrum of migraine. Med Clin North Am. 2001;85:897-909.
4. Cady R, Schreiber C, Farmer K, Sheftell F. Primary headaches: a convergence hypothesis. Headache. 2002;42:204-216.
5. Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. Med Clin North Am. 2001;85:911-941.
6. Williamson DJ, Hargreaves RJ. Neurogenic inflammation in the context of migraine. Microsc Res Tech. 2001;53:167-178.
7. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab. 1999;19:115-127.
8. Malick A, Burstein R. Peripheral and central sensitization during migraine. Funct Neurol. 2000;15(suppl 3):28-35.
9. Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003;43[suppl 1]:S9-S15.
10. Bogduk N, Marsland A. On the concept of third occipital headache. J Neurol Neurosurg Psychiatry. 1986;49:775-780.
11. Lord SM, Barnsley L, Wallis BJ, et al. Third occipital nerve headache: a prevalence study. J Neurol Neurosurg Psychiatry. 1994;57:1187-1190.
12. Aprill C, Axinn MJ, Bogduk N. Occipital headaches stemming from the lateral atlanto-axial (C1-2) joint. Cephalalgia. 2002;22:15-22.
13. Anthony M. Cervicogenic headache: prevalence and response to local steroid therapy. Clin Exp Rheumatol. 2000;8(2 suppl 19):S59-S64.